Clinical Trials Directory

Trials / Conditions / Intermediate Risk Prostate Cancer

Intermediate Risk Prostate Cancer

9 registered clinical trials studyying Intermediate Risk Prostate Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAndrogen-responsive POSLUMA-guided Intra-prostatic Boost
NCT07393867
Martin T. King, MD, PhDPhase 2
Active Not RecruitingCOMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)
NCT07455097
Heinrich-Heine University, Duesseldorf—
RecruitingThe PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
NCT06117059
NHS LothianN/A
Active Not RecruitingNeoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer
NCT05917860
Turku University HospitalPhase 1
TerminatedVAccination in Early and ADvanced Prostate caNCEr
NCT03815942
University of OxfordPhase 1 / Phase 2
TerminatedSpot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
NCT03740191
EBG MedAustron GmbHN/A
UnknownPROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.
NCT03340272
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia—
CompletedEnzalutamide + External Beam Rt For Prostate
NCT02028988
Dana-Farber Cancer InstitutePhase 2
CompletedAssessment of New Radiation Oncology Technologies and Treatments
NCT01379872
Trans Tasman Radiation Oncology Group—